🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate four different modified release formulation to est...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-10
Trial ID
NCT00988624
Treatments Being Tested
This drug-drug interaction study is being conducted to evaluate the potenti...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-11
Trial ID
NCT00788047
Treatments Being Tested
This study is to characterize the pharmacokinetics of single and multiple o...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-02
Trial ID
NCT00825084
This study has been designed to confirm, in healthy subjects, the lack of a...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-02
Trial ID
NCT00831506
This is a multi-center, randomized, double-blind placebo-controlled safety ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-02
Trial ID
NCT00838110
This study is being conducted to determine the safety and tolerability of D...
Status
Completed
Location
Huntington Study Group
Start Date
2006-10
Trial ID
NCT00387270
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of dim...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00829816
This study will evaluate the safety and potential benefit of Dimebon as com...
Status
Completed
Location
Mental Health Research Center of Russian Academy of Medical Sciences
Start Date
2005-09
Trial ID
NCT00377715
The purpose of this study is to determine if Dimebon is safe and effective ...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00920946
The purpose of this study is to evaluate the safety, tolerability and pharm...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-06
Trial ID
NCT00907322